{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:55:29Z","timestamp":1760244929395},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.humpath.2005.07.020","type":"journal-article","created":{"date-parts":[[2005,10,13]],"date-time":"2005-10-13T13:45:49Z","timestamp":1129211149000},"page":"1148-1151","source":"Crossref","is-referenced-by-count":31,"title":["Myelodysplastic\/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case"],"prefix":"10.1016","volume":"36","author":[{"given":"Simone","family":"Heiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Erdel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eberhard","family":"Gunsilius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Nachbaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandar","family":"Tzankov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2005.07.020_bib1","series-title":"WHO classification of tumors\u2014pathology and genetics of tumors of haematopoietic and lymphoid tissues","first-page":"47","article-title":"Myelodysplastic\/myeloproliferative diseases","author":"Vardiman","year":"2001"},{"year":"1995","series-title":"International system for human cytogenetic nomenclature","author":"Mitelman","key":"10.1016\/j.humpath.2005.07.020_bib2"},{"key":"10.1016\/j.humpath.2005.07.020_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0093-7754(01)90208-8","article-title":"The erythropoietin receptor","volume":"28","author":"Mulcahy","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1016\/j.humpath.2005.07.020_bib5","doi-asserted-by":"crossref","first-page":"32430","DOI":"10.1074\/jbc.271.50.32430","article-title":"Association of JAK2 and STAT5 with erythropoietin receptors. Role of receptor phosphorylation in erythropoietin signal transduction","volume":"271","author":"Sawyer","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humpath.2005.07.020_bib6","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood.V90.7.2535","article-title":"Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia","volume":"90","author":"Peeters","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2005.07.020_bib8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1432-1033.1997.00615.x","article-title":"The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs)","volume":"248","author":"Pellegrini","year":"1997","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.humpath.2005.07.020_bib9","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/jlb.57.6.813","article-title":"Interleukin-5 and its receptor: a drug target for eosinophilia associated with chronic allergic disease","volume":"57","author":"Devos","year":"1995","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.humpath.2005.07.020_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/10428199409049753","article-title":"Myelodysplastic syndrome with bone marrow eosinophilia: clinical and cytogenetic features","volume":"15","author":"Matsushima","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2005.07.020_bib11","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1038\/sj.onc.1207727","article-title":"The 8;21 translocation in leukemogenesis","volume":"23","author":"Peterson","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2005.07.020_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000046639","article-title":"The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1","volume":"107","author":"Macdonald","year":"2002","journal-title":"Acta Haematol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817705003862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817705003862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T08:21:37Z","timestamp":1586506897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817705003862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0046817705003862"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2005.07.020","relation":{},"ISSN":["0046-8177"],"issn-type":[{"type":"print","value":"0046-8177"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}